Trends Neurosci 2003 Feb;26(2):59-61
Colman D, Lubetzki C, Reingold S.
Montreal Neurological Institute, 3801 University Avenue, H3A 2B4, Montreal, PQ, Canada
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS, affecting approximately 1/1000 individuals in the Western world.
Available treatments limit CNS inflammation and strategies to repair damage in the CNS offer the potential of recovery of both tissue and function.
With further fundamental knowledge developing, this area is ripe for 'translation' to clinical application.